These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 28409556)
1. Knockdown of TMPRSS3, a Transmembrane Serine Protease, Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells. Wang JY; Jin X; Li XF Oncol Res; 2018 Jan; 26(1):95-101. PubMed ID: 28409556 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways. Li SL; Chen X; Wu T; Zhang XW; Li H; Zhang Y; Ji ZZ Biomed Pharmacother; 2018 Nov; 107():841-848. PubMed ID: 30142546 [TBL] [Abstract][Full Text] [Related]
3. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC. Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847 [TBL] [Abstract][Full Text] [Related]
4. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS. He F; Wei L; Luo W; Liao Z; Li B; Zhou X; Xiao X; You J; Chen Y; Zheng S; Li P; Murata M; Huang G; Zhang Z Oncotarget; 2016 Jun; 7(24):37000-37012. PubMed ID: 27203742 [TBL] [Abstract][Full Text] [Related]
5. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression. Peng H; Gong PG; Li JB; Cai LM; Yang L; Liu YY; Yao KT; Li X J Transl Med; 2016 May; 14(1):131. PubMed ID: 27170279 [TBL] [Abstract][Full Text] [Related]
6. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway. Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369 [TBL] [Abstract][Full Text] [Related]
7. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling. Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612 [TBL] [Abstract][Full Text] [Related]
8. Lactoferrin mediates epithelial-mesenchymal transformation by regulating the PI3K/AKT/mTOR pathway to inhibit nasopharyngeal carcinoma metastasis. Xu M; Fan Y; Zou G; Yang Q; Xu F Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):130-135. PubMed ID: 38650146 [TBL] [Abstract][Full Text] [Related]
9. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway. Wang B; Gu Q; Li J Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035 [TBL] [Abstract][Full Text] [Related]
10. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway. Hu W; Xiao L; Cao C; Hua S; Wu D Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030 [TBL] [Abstract][Full Text] [Related]
11. TMPRSS3 modulates ovarian cancer cell proliferation, invasion and metastasis. Zhang D; Qiu S; Wang Q; Zheng J Oncol Rep; 2016 Jan; 35(1):81-8. PubMed ID: 26531004 [TBL] [Abstract][Full Text] [Related]
12. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway. Wang SC; Lin XL; Wang HY; Qin YJ; Chen L; Li J; Jia JS; Shen HF; Yang S; Xie RY; Wei F; Gao F; Rong XX; Yang J; Zhao WT; Zhang TT; Shi JW; Yao KT; Luo WR; Sun Y; Xiao D Oncotarget; 2015 Nov; 6(34):36713-30. PubMed ID: 26452025 [TBL] [Abstract][Full Text] [Related]
13. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition. Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384. Qian W; Ren Z; Lu X Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220 [TBL] [Abstract][Full Text] [Related]
16. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro. Wang X; Jin Q; Wang X; Chen W; Cai Z Cancer Biomark; 2019; 26(2):171-182. PubMed ID: 31403940 [TBL] [Abstract][Full Text] [Related]
17. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts. Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682 [TBL] [Abstract][Full Text] [Related]
18. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway. Xie X; Xiong G; Chen W; Fu H; Li M; Cui X Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973 [TBL] [Abstract][Full Text] [Related]
19. AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells. Cao Q; Zhang J; Zhang T Biomed Res Int; 2018; 2018():9253036. PubMed ID: 29854811 [TBL] [Abstract][Full Text] [Related]
20. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2. Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]